Results 191 to 200 of about 1,083,667 (362)

Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial. [PDF]

Alzheimers Res Ther
Faridar A, Gamez N, Li D, Wang Y, Boradia R, Thome AD, Zhao W, Beers DR, Thonhoff JR, Nakawah MO, Román GC, Volpi JJ, Toledo JB, George M, Davis CS, Pascual B, Grundman M, Masdeu JC, Appel SH.   +18 more
europepmc   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

Capitalizing on opportunities and changing course: An experimental cell line model for T cell activation revealed a two signal model for Interleukin 2 transcript accumulation

Frontiers in Immunology, 2015
Arthur eWeiss, John D Stobo
doaj   +1 more source

Regulation of human T-lymphocyte gene expression by interleukin 2: immediate-response genes include the proto-oncogene c-myb. [PDF]

, 1987
C. David Pauza
openalex   +1 more source

Synthetic Cell‐Based Tissues for Bottom‐Up Assembly of Artificial Lymphatic Organs

Advanced Healthcare Materials, EarlyView.
Synthetic cells have emerged as a novel biomimetic approach for fundamental research and therapeutic interventions. T cell activating synthetic cells are able to form 3D tissue‐like structures by self‐assembly into lymphatic bottom‐up tissues (lymphBUT) with tunable biochemical and biomechanical functionalities as well as metabolic activity are ...
Anna Burgstaller, Tamara Nink, Niklas Walter, Erick Angel Lopez Lopez, Hsin‐Fang Chang, Oskar Staufer   +5 more
wiley   +1 more source

Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors. [PDF]

, 1988
Karen Kozarsky, S M Call, Steven Dower, Monty Krieger   +3 more
openalex   +1 more source

Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs

Advanced Healthcare Materials, EarlyView.
Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner, Stefan Keim, Soheil Haddadzadegan, Odile Fernandez Romero, Katrin Zöller, Gabriel Stern, Ilaria Cesi, Krum Kafedjiiski, Andreas Bernkop‐Schnürch   +8 more
wiley   +1 more source

Selectivity of bovine interleukin-2 mutein stimulation on bovine peripheral blood mononuclear cells. [PDF]

J Vet Med Sci
Mitoma S, Uto T, Fukaya T, Tominaga M, Sekiguchi S, Sato K, Norimine J.   +6 more
europepmc   +1 more source

Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations

, 1989
Kouichi Hisatomi, Tadashi Isomura, Takemi Kawara, Masayasu Yamashita, Akio Hirano, Hiroaki Yoshida, Naofumi Eriguchi, Kenichi Kosuga, Kiroku Ohishi   +8 more
openalex   +1 more source

Vicia villosa agglutinin separates freshly isolated Peyer's Patch T cells into interleukin 5- or interleukin 2-producing subsets. [PDF]

, 1989
Simone Schoenbeck, M J Hammen, Martin F. Kagnoff   +2 more
openalex   +1 more source